Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹109 Cr
Revenue (TTM)
₹25 Cr
Net Profit (TTM)
₹-14 Cr
ROE
-20.6 %
ROCE
-17.7 %
P/E Ratio
--
P/B Ratio
2.2
Industry P/E
44.74
EV/EBITDA
-7.5
Div. Yield
0 %
Debt to Equity
0.6
Book Value
₹14
EPS
₹-4.4
Face value
10
Shares outstanding
35,267,812
CFO
₹-29.20 Cr
EBITDA
₹-36.28 Cr
Net Profit
₹-33.48 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pharmaids Pharma
| -35.2 | -1.7 | -35.3 | -55.5 | 12.3 | 21.6 | 19.0 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Pharmaids Pharma
| -35.6 | 37.9 | 73.1 | 82.5 | -5.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pharmaids Pharma
|
30.9 | 108.9 | 25.5 | -15.3 | -75.8 | -28.2 | -- | 2.2 |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
Wholesale of pharmaceutical and medical goods
Incorporated
1989
Chairman
--
Managing Director
--
Headquarters
Bengaluru, Karnataka
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The share price of Pharmaids Pharmaceuticals Ltd is ₹30.89 (BSE) as of 02-Apr-2026 IST. Pharmaids Pharmaceuticals Ltd has given a return of 12.3% in the last 3 years.
Since, TTM earnings of Pharmaids Pharmaceuticals Ltd is negative, P/E ratio is not available.
The P/B ratio of Pharmaids Pharmaceuticals Ltd is 2.21 times as on 02-Apr-2026, a 29 discount to its peers’ median range of 3.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
4.08
|
|
2024
|
0.00
|
2.55
|
|
2023
|
0.00
|
2.13
|
|
2022
|
88.51
|
1.48
|
|
2021
|
122.99
|
1.35
|
The 52-week high and low of Pharmaids Pharmaceuticals Ltd are Rs 73.45 and Rs 27.10 as of 03-Apr-2026.
Pharmaids Pharmaceuticals Ltd has a market capitalisation of ₹ 109 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Pharmaids Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹2.29
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.